While headlines often focus on blockbuster drug approvals or updated clinical guidelines (e.g., screening recommendations), GLP-1s, which were theorized in 1906 and invented in 1986, demonstrate the potential magnitude of shifts in care delivery from a single therapeutic, which has important implications for provider financial viability, patient safety and access to care
"Gray-market medications are versions of prescription medications that are obtained outside of the usual prescription process," Dumont said
FDA Advisory Committee Recommends Adding BPC-157 to Compounding List A closely watched FDA advisory committee has voted to recommend adding BPC-157 to the list of bulk drug substances that may be used by traditional compounding pharmacies, marking a potentially significant development for providers who have followed growing interest in peptide therapies
I love how good this toner is on my skin
L-Carnitine / Levocarnitine may cause dizziness or fatigue in some individuals